Design, synthesis, and evaluation of novel heteroaromatic analogs of curcumin as anti-cancer agents

European Journal of Medicinal Chemistry

Volumn 75, Issue , 2014, Pages 123-131

  Samaan, Nawras ^a   Zhong, Qiu ^b   Fernandez, Jayjoel ^a   Chen, Guanglin ^a   Hussain, Ali M ^a   Zheng, Shilong ^b   Wang, Guangdi ^b   Chen, Qiao Hong ^a  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b XAVIER UNIVERSITY OF LOUISIANA   (United States)

Author keywords

Curcumin; Cytotoxicity; Heteroaromatic analogs; Prostate cancer

Indexed keywords

CURCUMIN; CYTOTOXICITY; HETEROAROMATIC ANALOGS; PROSTATE CANCER;

ANTINEOPLASTIC AGENTS; CELL DEATH; CELL LINE, TUMOR; CURCUMIN; DRUG DESIGN; DRUG SCREENING ASSAYS, ANTITUMOR; HELA CELLS; HUMANS; MALE; NEOPLASMS; PROSTATE; PROSTATIC NEOPLASMS;

EID: 84894224765     PISSN: 02235234     EISSN: 17683254     Source Type: Journal    
DOI: 10.1016/j.ejmech.2014.01.041     Document Type: Article

References (38)

1. American Cancer Society, What are the Key Statistics About Prostate Cancer, http://www.cancer.org/cancer/prostatecancer/detailedguide/prostate- cancer-key-statistics (last accessed on 10.11.13).
2. B.T. Feldman, and D. Feldman The development of androgen-independent prostate cancer Nat. Rev. Cancer 1 2001 34 35
3. C. Corcoran, S. Rani, K. O'Brien, A. O'Neil, M. Prencipe, R. Sheikh, G. Webb, R. McDermott, and W. Watson Docetaxel-resistance in prostate cancer: evaluating associated phenotylic changes and potential for resistance transfer via exosomes PLoS One 7 2012 e50999
4. L. Lin, B. Hutzen, S. Ball, E. Foust, M. Sobo, S. Deangelis, B. Pandit, L. Friedman, C. Li, P.-K. Li, D.M. Parkin, F. Brag, J. Ferlay, and P. Pisani Global cancer statistics Cancer J. Clin. 55 2005 74 108
5. B.B. Aggarwal, A. Kumar, and A.C. Bharti Anticancer potential of curcumin: preclinical and clinical studies Anticancer Res. 23 2003 363 398 (Pubitemid 36361976)
6. M.M. Chaturvedi, B. Sung, V.R. Yadav, R. Kannappan, and B.B. Aggarwal NF-kB addiction and its role in cancer: 'one size does not fit all' Oncogene 30 2011 1615 1630
7. B.B. Aggarwal Prostate cancer and curcumin Cancer Biol. Ther. 7 2008 1436 1440
8. M.-H. Teiten, F. Gaascht, S. Eifes, M. Dicato, and M. Diederich Chemopreventive potential of curcumin in prostate cancer Genes Nutr. 5 2010 61 74
9. G.R. Zimmermann, J. Lehar, and C.T. Keith Multi-target therapeutics: when the whole is greater than the sum of the parts Drug Discov. Today 12 2007 34 42 (Pubitemid 46014485)
10. A. Brown, Q. Shi, T.W. Moore, Y. Yoon, A. Prussia, C. Maddox, D.C. Liotta, H. Shim, and J.P. Snyder Monocarbonyl curcumin analogues: heterocyclic pleiotropic kinase inhibitors that mediate anticancer properties J. Med. Chem. 56 2013 3456 3466
11. R.A. Sharma, S.A. Euden, S.L. Platton, D.N. Cooke, A. Shafayat, H.R. Hewitt, T.H. Marczylo, B. Morgan, D. Hemingway, S.M. Plummer, M. Pirmohamed, A.J. Gescher, and W.P. Steward Phase I clinical trial of oral curcumin: biomarkers of systemic activity and compliance Clin. Cancer Res. 10 2004 6847 6854 (Pubitemid 39383033)
12. H. Zhou, C.S. Beevers, and S. Huang Targets of curcumin Curr. Drug Targets 12 2011 332 347
13. P. Anand, A.B. Kunnumakkara, R.A. Newman, and B.B. Aggarwal Bioavailability of curcumin: problems and promises Mol. Pharm. 4 2007 807 818
14. G. Garcea, D.J. Jones, R. Singh, A.R. Dennison, P.B. Farmer, R.A. Sharma, W.P. Steward, A.J. Gescher, and D.P. Berry Br. J. Cancer 90 2004 1011 1015
15. H. Ohtsu, Z. Xiao, J. Ishida, M. Nagai, H. Wang, H.S. Itokawa, C. Shih, T. Chiang, E. Chang, Y. Lee, M. Tsai, C. Chang, and K.-H. Lee Antitumor agents. 217. Curcumin analogues as novel androgen receptor antagonists with potential as antiprostate cancer agents J. Med. Chem. 45 2002 5037 5042 (Pubitemid 35278699)
16. G. Liang, L. Shao, Y. Wang, C. Zhao, Y. Chu, J. Xiao, Y. Zhao, X. Li, and S. Yang Exploration and synthesis of curcumin analogues with improved structural stability both in vitro and in vivo as cytotoxic agents Bioorg. Med. Chem. 17 2009 2623 2631
17. L. Lin, Q. Shi, C.Y. Su, C.C. Shih, and K.-H. Lee Antitumor agents 247. New 4-ethoxycarbonylehtyl curcumin analogs as potential antiandrogenic agents Bioorg. Med. Chem. 14 2006 2527 2534 (Pubitemid 43343639)
18. L. Lin, Q. Shi, A.K. Nyarko, K.F. Bastow, C.C. Wu, C.Y. Su, C.C. Shih, and K.-H. Lee Antitumor agents. 250. Design and synthesis of new curcumin analogues as potential anti-prostate cancer agents J. Med. Chem. 49 2006 3963 3972 (Pubitemid 43970710)
19. L. Lin, B. Hutzen, S. Ball, E. Foust, M. Sobo, S. Deangelis, B. Pandit, L. Friedman, C. Li, P.K. Li, J. Fuchs, and J. Lin New curcumin analogues exhibit enhanced growth-suppressive activity and inhibit AKT and signal transducer and activator of transcription 3 phosphorylation on breast and prostate cancer cells Cancer Sci. 100 2009 1719 1727
20. X. Wei, D. Zhou, H. Wang, N. Ding, X.-X. Cui, H. Wang, M. Verano, K. Zhang, A. Conney, X. Zheng, and Z.-Y. Du Effects of pyridine analogs of curcumin on growth, apoptosis and NF-κB activity in prostate cancer PC-3 cells Anticancer Res. 33 2013 1343 1350
21. H. Itokawa, Q. Shi, T. Akiyama, S.L. Morris-Natschke, and K.-H. Lee Recent advances in the investigation of curcuminoids Chin. Med. 3 2008 11
22. K.-H. Lee Discovery and development of natural product-derived chemotherapeutic agents based on a medicinal chemistry approach J. Nat. Prod. 73 2010 500 516
23. J.R. Fuchs, B. Pandit, D. Bhasin, J.P. Etter, N. Regan, D. Abdelhamid, C. Li, J. Lin, and P.K. Li Structure-activity relationship studies of curcumin analogues Bioorg. Med. Chem. Lett. 19 2009 2065 2069
24. J. Ishida, H. Ohtsu, Y. Tachibana, Y. Nakanishi, K.F. Bastow, M. Nagai, H. Wang, H. Itokawa, and K. Lee Antitumor agents. part 214: synthesis and evaluation of curcumin analogues as cytotoxic agents Bioorg. Med. Chem. 10 2002 3481 3487
25. A.P. Kumar, G.E. Varcia, R. Ghosh, R.V. Fajnarayanan, W.L. Alworth, and T.J. Slaga 4-Hydrocy-3-methoxybenzoic acid methyl ester: a curcumin derivative targets Akt/NF kappa B cell survival signaling pathway. Potential for prostate cancer management Neoplasia 5 2003 255 266 (Pubitemid 36754055)
26. Q. Shi, C.C. Shih, and K.-H. Lee Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity Anticancer Agents Med. Chem. 9 2009 904 912
27. Q. Shi, K. Wada, E. Ohloshi, L. Lin, R. Huang, S.L. Morris-Natschke, M. Goto, and K.-H. Lee Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCap and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens Bioorg. Med. Chem. 20 2012 4020 4031
28. A. Valentini, F. Conforti, A. Crispini, A. De Martino, R. Condello, C. Stellitano, G. Rotilio, M. Ghedini, G. Federici, S. Bernardini, and D. Pucci Synthesis, oxidant properties, and antitumoral effects of heteroleptic palladium (II) complex of curcumin on human prostate cancer cells J. Med. Chem. 52 2009 484 491
29. M.J. Rosemond, L. St John-Williams, T. Yamaguchi, T. Fujishita, and J.S. Walsh Enzymology of a carbonyl reduction clearance pathway for the HIV integrase inhibitor, S-1360: role of human liver cytosolic aldo-keto Chem. Biol. Interact. 147 2004 129 139 (Pubitemid 38324542)
30. Y.J. Wang, M.H. Pan, A.L. Cheng, L.I. Lin, Y.S. Ho, C.Y. Hsieh, and J.K. Lin Stability of curcumin in buffer solutions and characterization of its degradation products J. Pharm. Biomed. Anal. 15 1997 1867 1876
31. B. Yadav, S. Taurin, R.J. Rosengren, M. Schumacher, M. Diederich, T.J. Somers-Edgar, and L. Larsen Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin Bioorg. Med. Chem. 18 2010 6701 6707
32. S. Zhu, T.W. Moore, X. Lin, N. Morii, A. Mancini, R.B. Howard, D. Culver, R.F. Arrendale, P. Reddy, T.J. Evers, H. Zhang, G. Sica, Z.G. Chen, A. Sun, H. Fu, F.R. Khuri, D.M. Shin, J.P. Snyder, and M. Shoji Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma Integr. Biol. 4 2012 633 640
33. X. Wei, Z.Y. Du, X. Zheng, X.X. Cui, A.H. Conney, and K. Zhang Synthesis and evaluation of curcumin-related compounds for anticancer activity Eur. J. Med. Chem. 53 2012 235 245
34. B. Cao, Y. Wang, K. Ding, N. Neamati, and Y.-Q. Long Synthesis of the pyridinyl analogues of dibenzylideneacetone (pyr-dba) via an improved Claisen-Schmidt condensation, displaying diverse biological activities as curcumin analogues Org. Biomol. Chem. 10 2012 1239 1245
35. M. Seto, N. Miyamoto, K. Aikawa, Y. Aramaki, N. Kanzaki, Y. Iizawa, M. Baba, and M. Shiraishi Orally active CCR5 antagonists as anti-HIV-1 agents. Part 3: synthesis and biological activities of 1-benzazepine derivatives containing a sulfoxide moiety Bioorg. Med. Chem. 13 2005 363 386 (Pubitemid 39642920)
36. C.S. Marvel, and J.K. Stille Preparation of the pyridalacetones and the inductive effect of nitrogen on the dehydration of the intermediate J. Org. Chem. 22 1957 1451 1457
37. W. Wichitnithad, U. Nimmannit, S. Wacharasindhu, and P. Rojsitthisak Synthesis, characterization and biological evaluation of succinate prodrugs of curcuminoids for colon cancer treatment Molecules 16 2011 1888 1900
38. Q. Jiang, Q. Zhong, Q. Zhang, S. Zheng, and G. Wang Discovery of a series of thiazole derivatives as novel inhibitors of metastatic cancer cell migration and invasion ACS Med. Chem. Lett. 3 2012 392 396